Dr. James Greenblatt is a globally recognized pioneer in functional and integrative psychiatry with over 30 years of clinical experience. He has dedicated his career to transforming the treatment of mental health disorders through precision-based approaches that integrate laboratory testing, nutritional interventions, and root-cause analysis. Dr. Greenblatt earned his medical degree and completed a psychiatry residency at George Washington University, and pursued a Child and Adolescent Psychiatry fellowship at Johns Hopkins Medical School.
A prolific author, Dr. Greenblatt has written eight books, including the bestseller Finally Focused: The Breakthrough Natural Treatment Plan for ADHD. He serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College’s Geisel School of Medicine. Previously, he served as Chief Medical Officer for Walden Behavioral Care/Monte Nido, a national mental health organization specializing in eating disorders.
In 2019, Dr. Greenblatt founded Psychiatry Redefined, a leading platform for continuing education for clinicians in functional and integrative psychiatry, designed to bridge critical knowledge gaps for mental health professionals. His innovative work combines evidence-based research with decades of clinical expertise in functional and integrative psychiatry to promote personalized, precision medicine approaches for sustainable mental health outcomes. in 2024, Dr. Greenblatt founded Mind Refined, a consumer education platform in functional and integrative approaches to mental healthcare.
Dr. Greenblatt lectures internationally on nutritional psychiatry and functional medicine’s transformative role in treating mental illnesses.
Dr. Daniel Dowd is Genomind’s Chief Clinical Officer. His responsibilities at Genomind include building and managing a mental health medical affairs team of PharmDs and PhDs. Dr. Dowd is also intimately involved with product development, genetic research, medical education programs and pharmacy integrations.
He is a PharmD licensed in New York and New Jersey and has over 15 years of unique experience across community pharmacy management, medical affairs and healthcare education. Prior to joining Genomind, Dr. Dowd held positions as district and regional director of community pharmacy training and operations for several pharmacies including Rite Aid and A&P. For 13 years, he also developed and taught advanced pharmacology courses at the City University of New York (CUNY). Dr. Dowd has published on the implementation of pharmacogenetics in psychiatry and has been interviewed by national media outlets, including Drug Topics, JAMA Medical News and Perspectives and the Dr. Oz show. He is a member of the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the American Society of Pharmacovigilance STRIPE Collaborative Community.